Start with its own history
At 3.49×, TAKE.BO is 81.4% below its 5-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
3.49×
81.4% belowthe 5-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 3.49 for every 1 of reported earnings per share.
Annual period-end data · 19 observations
| Period end | P/E | Change |
|---|---|---|
| Mar 31, 2026 | 53.54× | +1852.5% |
| Mar 31, 2025 | 2.74× | N/M |
| Mar 31, 2024 | N/M | N/M |
| Mar 31, 2023 | N/M | N/M |
| Mar 31, 2022 | N/M | N/M |
| Mar 31, 2021 | N/M | N/M |
| Mar 31, 2020 | N/M | N/M |
| Mar 31, 2019 | 12.45× | -10.9% |
| Period end | P/E | Change |
|---|---|---|
| Mar 31, 2018 | 13.97× | +24.2% |
| Mar 31, 2017 | 11.25× | -21.1% |
| Mar 31, 2016 | 14.25× | -35.5% |
| Mar 31, 2015 | 22.10× | +225.9% |
| Mar 31, 2014 | 6.78× | +96.0% |
| Mar 31, 2013 | 3.46× | -27.5% |
| Mar 31, 2012 | 4.77× | -21.2% |
| Mar 31, 2011 | 6.05× | -32.4% |
| Mar 31, 2010 | 8.96× | +116.9% |
| Mar 31, 2009 | 4.13× | -74.6% |
| Mar 31, 2008 | 16.28× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
TAKE.BO This stockTAKE Solutions Limited | 3.49× |
LYKALABS.NSLyka Labs Limited | N/M |
LYKALABS.BOLyka Labs Limited | N/M |
SMSLIFE.NSSMS Lifesciences India Limited | 38.10× |
SMSLIFE.BOHaleos Labs Limited | 38.10× |
BROOKS.NSBrooks Laboratories Limited | 2.71× |
BROOKS.BOBrooks Laboratories Limited | 2.71× |
NECLIFE.BONectar Lifesciences Limited | N/M |
TLL.BOTrident Lifeline Limited | 20.63× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 3.49×, TAKE.BO is 81.4% below its 5-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 5 positive peer ratios above is 20.63×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("TAKE.BO", "PE Ratio", "LQ")Share price 12.71 ÷ EPS 3.6464 = 3.49×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 18, 2026; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.